Century Therapeutics, Inc. (IPSC) Net margin 2022–2025
Century Therapeutics, Inc. (IPSC) net profit margin by fiscal year — reported net income divided by reported revenue.
-8.8%FY2025 · since FY2022: -2518.4% → -8.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8.8% | +1912.1 pp |
| FY2024 | -1920.9% | +4194.3 pp |
| FY2023 | -6115.1% | -3596.7 pp |
| FY2022 | -2518.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice